Addex Therapeutics Ltd ADR (ADXN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -16,797 | -11,906 | -8,046 | -2,918 | -13,715 |
| Depreciation Amortization | 380 | 288 | 194 | 98 | 399 |
| Accounts receivable | -106 | -142 | -64 | -5 | 53 |
| Accounts payable and accrued liabilities | 967 | 485 | 966 | 1,660 | -1,691 |
| Other Working Capital | -653 | -1,670 | -2,288 | 375 | -1,638 |
| Other Operating Activity | 119 | 133 | -885 | -2,271 | 3,601 |
| Operating Cash Flow | $-16,089 | $-12,813 | $-10,122 | $-3,061 | $-12,991 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -35 | -8 | -6 | -4 | -63 |
| Sale Of Investment | 1 | 1 | N/A | N/A | N/A |
| Investing Cash Flow | $-33 | $-6 | $-6 | $-4 | $-63 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 17,103 | 11,071 | 11,155 | 11,233 | N/A |
| Common Stock Repurchased | 4,154 | 60 | 60 | 29 | 768 |
| Other Financing Activity | -3,310 | -2,147 | -2,064 | -1,543 | -719 |
| Financing Cash Flow | $17,946 | $8,984 | $9,151 | $9,719 | $50 |
| Exchange Rate Effect | 134 | 339 | 333 | 558 | -692 |
| Beginning Cash Position | 20,454 | 20,368 | 20,522 | 20,666 | 33,637 |
| End Cash Position | 22,413 | 16,872 | 19,877 | 27,878 | 19,940 |
| Net Cash Flow | $1,958 | $-3,496 | $-644 | $7,213 | $-13,697 |
| Free Cash Flow | |||||
| Operating Cash Flow | -16,089 | -12,813 | -10,122 | -3,061 | -12,991 |
| Capital Expenditure | -35 | -8 | -6 | -4 | -63 |
| Free Cash Flow | -16,123 | -12,821 | -10,128 | -3,064 | -13,055 |